Scope
A focused summary of the AAD good practice statement for adults with presumed atopic dermatitis that remains refractory to treatment. The available recommendation supports reconsidering the diagnosis; the detailed testing scenarios in the full guideline are outside this summary.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Reconsider the diagnosis when treatment fails
- In adults whose presumed atopic dermatitis remains unresponsive to management, consider further diagnostic workup. This is a good practice statement supporting reassessment, rather than a requirement to order a particular test in every patient. [2]
Limitations and use
- This focused source bundle contains the exact single Good Practice Statement reproduced by Guideline Central and the AAD official scope statement. The full final guideline and its detailed testing scenarios were not acquired.
- These excerpts support considering further workup or diagnostic reassessment in adults with presumed atopic dermatitis unresponsive to management. They do not establish which specific test to order, an ordering sequence, universal testing requirements, or a treatment algorithm.
- This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Diagnostic testing for treatment-refractory presumed atopic dermatitis — reviewed source bundle part 1
Selected recommendation material consulted
- Diagnostic testing for treatment-refractory presumed atopic dermatitis — reviewed source bundle part 2
Selected recommendation material consulted
Publication details
- Issuing organisation
- AAD
- First published
- 31 August 2026
- Resource type
- Clinical practice guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.